Elbasvir plus grazoprevir for patients with chronic hepatitis C genotype 1: A multicenter, real-world cohort study focusing on chronic kidney disease.
Ogawa E, Furusyo N, Azuma K, Nakamuta M, Nomura H, Dohmen K, Satoh T, Kawano A, Koyanagi T, Ooho A, Takahashi K, Kato M, Shimoda S, Kajiwara E, Hayashi J; Kyushu University Liver Disease Study (KULDS) Group.
Ogawa E, et al. Among authors: kato m.
Antiviral Res. 2018 Nov;159:143-152. doi: 10.1016/j.antiviral.2018.10.003. Epub 2018 Oct 6.
Antiviral Res. 2018.
PMID: 30300717